W.R. Berkley Corp’s Audentes Therapeutics, Inc BOLD Stock Holding History

W.R. Berkley Corp’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-43,800	Closed	-$2.62M	–	145
2019 Q4	$2.62M	Buy	+43,800	New	+$1.64M	0.48%	52

W.R. Berkley Corp's BOLD Position: Q1 2020 in Review

W.R. Berkley Corp sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 43,800 shares — an estimated $2.62M sold.

W.R. Berkley Corp first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $2.62M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

W.R. Berkley Corp reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
W.R. Berkley Corp sold 43,800 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2.62M.
W.R. Berkley Corp first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
W.R. Berkley Corp's Audentes Therapeutics, Inc position peaked at $2.62M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on W.R. Berkley Corp's 13F filing for Q1 2020, filed 15 May 2020.